UC Irvine TODAY UC Irvine homepage UC Irvine TODAY

UC Irvine TODAY

News

News

Wednesday, April 23, 2014

News Brief

Email this page to a friend EmailPrinter friendly page PrintShare Share
May 31, 2012 3:35 p.m.

UCI-created stem cell treatment passes safety phase of clinical trial

Aileen Anderson and Brian Cummings
Doctors with the Balgrist University Hospital in Zurich have reported that a stem cell treatment developed in a collaboration among UCI's Aileen Anderson and Brian Cummings (pictured), the campus's Sue & Bill Gross Stem Cell Research Center and StemCells Inc. has passed the first planned interim safety review of the Phase I/II spinal cord injury clinical trial, which indicates that the surgery, immunosuppression and cell transplants have been well tolerated. The StemCells Inc.-sponsored trial is the only ongoing clinical study of neural stem cell transplantation in spinal cord injury. Enrollment is now open to patients in Europe, the U.S. and Canada with "incomplete" spinal cord injury.

Media Contact
Related topics: Clinical Trials, Anderson, Cummings, Anatomy & Neurobiology, Physical Medicine & Rehabilitation, Health & Medicine, Faculty, Students, Alumni, Public, Medicine, Stem Cells
University of California, Irvine
University of California, Irvine - Irvine, CA 92697 : 949-824-5011
Comments & Questions | Privacy & Legal Notice | Copyright Inquiries | © 2014 UC Regents